Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 83

    Fight against Rabies: India hands over 10k vials of anti-rabies vaccines to Myanmar

    Fight against Rabies: India hands over 10k vials of anti-rabies vaccines to Myanmar

    Medical Dialogues Bureau9 Oct 2019 9:35 AM IST
    In a handing over ceremony held in Yangon on Tuesday, the Deputy Chief of Mission Sumit Seth handed over the vials of Anti-Rabies Vaccines to...
    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure

    Medical Dialogues Bureau9 Oct 2019 9:30 AM IST
    GSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
    Regulatory interventions constraining Profitability of Indian pharma: ICRA

    Regulatory interventions constraining Profitability of Indian pharma: ICRA

    Medical Dialogues Bureau8 Oct 2019 4:53 PM IST
    "But revenues continue to be impacted by price erosion, product rationalisation and continued effect of regulatory overhang for certain companies...
    Glenmark shares fall 9pc on USFDA warning letter for Baddi facility

    Glenmark shares fall 9pc on USFDA warning letter for Baddi facility

    Medical Dialogues Bureau8 Oct 2019 3:08 PM IST
    Drug firm Glenmark Pharmaceuticals on Saturday said it has received a warning letter from the United States Food and Drug Administration (USFDA) for...
    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Medical Dialogues Bureau8 Oct 2019 2:54 PM IST
    The United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
    Shilpa Medicare gets final USFDA approval for Gemcitabine Injection

    Shilpa Medicare gets final USFDA approval for Gemcitabine Injection

    Medical Dialogues Bureau8 Oct 2019 9:45 AM IST
    Gemcitabine Injection is used in the treatment of Ovarian Cancer, Breast Cancer, Non-Small Cell Lung Cancer and Pancreatic Cancer as recommended in...
    Takeda Pharma, Prometheus Biosciences collaborate to develop therapies for IBD

    Takeda Pharma, Prometheus Biosciences collaborate to develop therapies for IBD

    Medical Dialogues Bureau8 Oct 2019 9:15 AM IST
    Under the terms of the agreement, Prometheus Biosciences will receive an undisclosed initial upfront payment from Takeda and is eligible to receive up...
    CDSCO Committee to draft new guidelines for effective recall of substandard drugs

    CDSCO Committee to draft new guidelines for effective recall of substandard drugs

    Farhat Nasim7 Oct 2019 5:29 PM IST
    New Delhi: To examine the issues regarding effective recall system of drugs found Not of Standard Quality (NSQ) and to review the recall guidelines...
    Dr Reddys gets Establishment Inspection Report from USFDA for Bollaram facility

    Dr Reddys gets Establishment Inspection Report from USFDA for Bollaram facility

    Medical Dialogues Bureau7 Oct 2019 2:28 PM IST
    New Delhi: Hyderabad-based drug major, Dr Reddy's Laboratories has received an Establishment Inspection Report (EIR) from the US Health regulator for...
    Indoco Remedies Parkinsons drug Rasagiline gets USFDA okay

    Indoco Remedies Parkinsons drug Rasagiline gets USFDA okay

    Medical Dialogues Bureau7 Oct 2019 1:23 PM IST
    New Delhi: Drugmaker, Indoco Remedies today received the US health regulator's final nod for Rasagiline 0.5 mg and 1 mg tablets for treating...
    Glenmark API facility in Baddi gets USFDA warning letter

    Glenmark API facility in Baddi gets USFDA warning letter

    Medical Dialogues Bureau7 Oct 2019 11:47 AM IST
    The Baddi facility is expected to contribute USD 30 million in total sales for this financial year which is about 7 per cent of the total US sales,...
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    Medical Dialogues Bureau7 Oct 2019 9:30 AM IST
    NEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok